ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

616-collision-tumour-of-large-cell-neuroendocrine-carcinoma-and-adenocarcinoma-in-the-stomach-a-case-report

Case Report: Collision tumour of large-cell neuroendocrine carcinoma and adenocarcinoma in the stomach: A case report

Eduardo Payet, Pau I Pilco, Jaime Montes, Alejandra Cordero-Morales, Maria Jose Savitzky, Karoline Stenning-Persivale

29 Jan 2016

https://doi.org/10.3332/ecancer.2016.616

Abstract | Full Article | PDF

582-effectiveness-and-safety-of-monoclonal-antibodies-for-metastatic-colorectal-cancer-treatment-systematic-review-and-meta-analysis

Review: Effectiveness and safety of monoclonal antibodies for metastatic colorectal cancer treatment: systematic review and meta-analysis

Bruno Rosa, José Paulo de Jesus, Eduardo L de Mello, Daniel Cesar, Mauro M Correia

15 Oct 2015

https://doi.org/10.3332/ecancer.2015.582

Abstract | Full Article | PDF | Portuguese

581-aspirin-in-the-21st-century-common-mechanisms-of-disease-and-their-modulation-by-aspirin-a-report-from-the-2015-scientific-conference-of-the-international-aspirin-foundation-28-august-london-uk

Conference Report: Aspirin in the 21st century—common mechanisms of disease and their modulation by aspirin: a report from the 2015 scientific conference of the international aspirin foundation, 28 August, London, UK

Tom Smith, Pippa Hutchison, Karsten Schrör, Joan Clària, Angel Lanas, Paola Patrignani, Andrew T Chan, Farhat Din, Ruth Langley, Peter Elwood, Andrew Freedman, Ron Eccles

13 Oct 2015

https://doi.org/10.3332/ecancer.2015.581

Abstract | Full Article | PDF

568-repurposing-drugs-in-oncology-redo-nitroglycerin-as-an-anti-cancer-agent

Clinical Study: Repurposing Drugs in Oncology (ReDO)—nitroglycerin as an anti-cancer agent

Vidula Sukhatme, Gauthier Bouche, Lydie Meheus, Vikas P Sukhatme, Pan Pantziarka

27 Aug 2015

https://doi.org/10.3332/ecancer.2015.568

Abstract | Full Article | PDF

$563-phase-ii-trial-of-metformin-and-paclitaxel-for-patients-with-gemcitabine-refractory-advanced-adenocarcinoma-of-the-pancreas$

Clinical Study: Phase II trial of metformin and paclitaxel for patients with gemcitabine-refractory advanced adenocarcinoma of the pancreas

Maria Ignez Braghiroli, Anezka C R de Celis Ferrari, Tulio Eduardo Pfiffer, Alexandra Kichfy Alex, Daniela Nebuloni, Allyne S Carneiro, Fernanda Caparelli, Luiz Senna, Juliana Lobo, Paulo Marcelo Hoff, Rachel P Riechelmann

11 Aug 2015

https://doi.org/10.3332/ecancer.2015.563

Abstract | Full Article | PDF

560-serum-anti-p53-antibody-as-a-tumour-marker-for-colorectal-cancer-screening

Case Report: Serum anti-p53 antibody as a tumour marker for colorectal cancer screening

Masaya Iwamuro, Yoshinara Kawai, Tomoko Matsumoto, Masashi Uda, Hiroyuki Okada

29 Jul 2015

https://doi.org/10.3332/ecancer.2015.560

Abstract | Full Article | PDF

553-lessons-from-the-first-ecancer-symposium-on-angiogenesis-in-gastric-cancer

Conference Report: Lessons from the first ecancer symposium on angiogenesis in gastric cancer

Audrey Nailor, Elisabetta Dejana, Andrew R Reynolds, Shonit Punwani, Giuseppe Curigliano, Francesco Bertolini, Manish Shah, Romano Danesi, Robert Kerbel, Gordon McVie

21 Jul 2015

https://doi.org/10.3332/ecancer.2015.553

Abstract | Full Article | PDF